Cipher Pharmaceuticals Inc. (TSE:CPH – Get Free Report) (NASDAQ:CPHR) shares hit a new 52-week high during trading on Wednesday . The stock traded as high as C$17.37 and last traded at C$17.24, with a volume of 28602 shares changing hands. The stock had previously closed at C$16.85.
Cipher Pharmaceuticals Price Performance
The business has a 50-day moving average price of C$15.07 and a 200-day moving average price of C$14.97. The stock has a market cap of C$423.68 million, a PE ratio of 15.90 and a beta of 1.33. The company has a current ratio of 1.12, a quick ratio of 2.67 and a debt-to-equity ratio of 4.36.
About Cipher Pharmaceuticals
Cipher Pharmaceuticals (TSX: CPH) (OTCQX: CPHRF) is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products, mainly in dermatology. Cipher acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and currently markets those products in Canada, the U.S., and South America.
Further Reading
Receive News & Ratings for Cipher Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cipher Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
